Search
bioAffinity Technologies Inc
BIAFAdd to Watchlist
9.430USD
+0.680+7.77%
Close 09-18 16:00（ET）
4.23MMarket Cap
LossP/E TTM
Pre-market 08:03 (ET)9.080USD-0.350-3.71%
Pre-market 08:03 (ET)BIAF Analyst Recommendation Trends
In the current month, BIAF has received 0 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. BIAF average Analyst price target in the last month is 6.000.
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
2026-03
2026-02
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
BIAF Analyst Rating for Peer Comparison
Updated: Sep 20, 2026Company name
Strong Buy
Buy
Hold
Sell
Strong Sell
Analysts
Stryker Corp
SYK
11
13
6
0
0
30
Medtronic PLC
MDT
9
10
11
0
0
30
Dexcom Inc
DXCM
13
13
4
0
0
30
Zimmer Biomet Holdings Inc
ZBH
2
6
21
0
0
29
Abbott Laboratories
ABT
11
12
6
0
0
29
Medline Ord Shs Class A
MDLN
10
12
6
0
0
28
Insulet Corp
PODD
7
8
12
0
0
27
Guardant Health Inc
GH
12
13
2
0
0
27
Repligen Corp
RGEN
5
14
3
0
0
22
Tandem Diabetes Care Inc
TNDM
4
8
10
0
0
22
Financial Forecasting
Based on analysts' estimates, BIAF EPS is projected to reach -2.100 in FY2026Q3, following reported EPS of -9.660 in FY2026Q2. Track earnings expectations against reported figures to see how profitability is evolving.
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2025Q4
FY2026Q1
FY2026Q2
FY2026Q3
Forecast
-2.70
-2.40
-2.10
-2.10
Actual
-0.70
-0.81
-9.66
--
Surprise
+74.01%
+66.34%
-360.01%
--
FAQs
What is bioAffinity Technologies Inc's expected revenue for the next quarter?
bioAffinity Technologies Inc's expected revenue is 1.91M.
How have bioAffinity Technologies IncBIAF's recent earnings per share performed?
The market expectation was USD -9.66, while bioAffinity Technologies IncBIAF's earnings per share (EPS) for the previous quarter was USD -0.81. EPS for the next quarter is expected at USD -2.10.
What is the analyst rating for bioAffinity Technologies Inc?
Based on the ratings of bioAffinity Technologies Inc's stock from 0 analysts, most analysts support a signal_hold trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as signal_hold. Please note that this is not trading advice. You still need to conduct your own analysis.